Journal article
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
- Abstract:
-
BACKGROUND: Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. The next two drugs to be developed were didanosine (ddI) and zalcitabine (ddC). OBJECTIVES: To assess the effects of zidovudine (AZT), zidovudine plus didanosine (ddI) and zidovudine plus zalcitabine (ddC) on HIV disease progression and survival. SEARCH STRATEGY: Investigators and pharmaceutical companies were contacted, and MEDLINE searches were supplemented by searching conference abstracts. SEL...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Cochrane database of systematic reviews
- Issue:
- 3
- Pages:
- CD002038
- Publication date:
- 2000-01-01
- DOI:
- EISSN:
-
1469-493X
- ISSN:
-
1469-493X
- Source identifiers:
-
196434
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:196434
- UUID:
-
uuid:c90cac5c-5ff7-4bc4-895c-773fae60b384
- Local pid:
- pubs:196434
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2000
If you are the owner of this record, you can report an update to it here: Report update to this record